Bloomberg
Mine nyheder

Vi har ikke publiceret nogle artikler for nyligt i de emner, du følger. Søg efter andre emner her.

Du har ingen overvågninger endnu

Klik på ikonet for at overvåge
emner og journalister.

In superbug war, reliance on just a few drugmakers fuels concern

Der forskes for lidt i antibiotika til bekæmpelse af multiresistente bakterier. Foto: AP/Armin Weigel

A dependence on only a few pharma companies to sustain the fight against superbugs is putting the world in a precarious position, a new report shows.

Progress in tackling drug-resistant infections isn't keeping pace with the rising threat, according to the latest Antimicrobial Resistance Benchmark, published Tuesday by the Access to Medicine Foundation. The pipeline of new antibiotics in advanced tests remains too small, the nonprofit found...

BRANCHENYT
Læs også